The NCDB was queried to assess the optimal timing for resection after induction therapy for IIIA NSCLC. Survival was better in patients who underwent surgery in a short delay interval (114 days); short and medium delay intervals had similar outcomes.
You are here:
Optimal Surgical Timing After Neoadjuvant Therapy for Stage IIIa Non-Small Cell Lung Cancer
Submitted by: Emily Robinson
Source: The Annals of Thoracic Surgery
Source URL: https://doi.org/10.1016/j.athoracsur.2019.09.076
Keywords:
Author(s): Jonathan D. Rice, Justin Heidel, Jaimin R. Trivedi, Victor H. van Berkel
